共 50 条
Dinuclear silver and gold bisNHC complexes as drug candidates for cancer therapy
被引:9
|作者:
Quintana, Mireia
[1
]
Rodriguez-Rius, Alba
[1
]
Velle, Alba
[2
]
Vives, Sonia
[1
]
Sanz Miguel, Pablo J.
[2
]
Triola, Gemma
[1
]
机构:
[1] CSIC, Dept Quim Biol, Inst Quim Avanzada Cataluna IQAC, Jordi Girona 18-26, Barcelona 08034, Spain
[2] Univ Zaragoza, Inst Sintesis Quim & Catalisis Homogenea ISQCH, Dept artarnento Quim Inorgan, CSIC, Zaragoza 50009, Spain
关键词:
Gold;
Silver;
N -heterocyclic carbene;
Ovarian cancer;
Oxidative stress;
THIOREDOXIN REDUCTASE;
CARBENE COMPLEXES;
CELL-LINES;
INHIBITION;
APOPTOSIS;
MECHANISMS;
EXPRESSION;
REACTIVITY;
PLATINUM;
SYSTEM;
D O I:
10.1016/j.bmc.2022.116814
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
We report four dinuclear silver(I) and gold(I) complexes containing two different bidentate N-heterocyclic carbene ligands (bisNHC). One of these complexes 4, shows strong and selective anticancer activity against the human ovarian cancer cell line A2780. Mechanistically, 4 enhances the oxidative stress by stimulating reactive oxygen species production and inhibiting the scavenging activity of thioredoxin reductase. Our findings provide evidence that tuning ligand and electronic properties of metal-NHC complexes can modulate their reactivity and selectivity and it may result in potential novel anticancer drugs.
引用
收藏
页数:8
相关论文